Health product recall

PegLyte Powder: Affected lots may contain foreign matter

Brand(s)
Last updated

Summary

Product
PegLyte Powder
Issue
Health products - Contamination
What to do

Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.

Distribution
National

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot Number

Pendopharm

PegLyte Powder

DIN 00777838

Powder For Solution

Macrogol 238.18 g / Potassium Chloride 3.05 g / Sodium Bicarbonate 6.76 g / Sodium Chloride 5.85 g / Sodium Sulfate 22.96 g

260303
260304
260305
260306

Issue

The affected lots may contain foreign matter.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of Recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Pendopharm Division of Pharmascience Inc.
6111 avenue Royalmount, suite 100

Montréal, QC H4P 2T4

Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type III
Identification number
RA-82964

Get notified

Receive emails about new and updated recall and safety alerts.

Subscribe